ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 114 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $37 | -64.1% | 12,208 | -72.4% | 0.00% | -71.4% |
| Q4 2022 | $103 | -99.9% | 44,194 | -16.2% | 0.01% | +16.7% |
| Q2 2022 | $143,000 | -49.3% | 52,722 | -43.4% | 0.01% | -55.6% |
| Q2 2021 | $282,000 | +32.4% | 93,196 | +45.8% | 0.03% | +80.0% |
| Q1 2021 | $213,000 | -4.1% | 63,941 | +2.3% | 0.02% | -37.5% |
| Q4 2020 | $222,000 | +616.1% | 62,530 | +264.7% | 0.02% | +500.0% |
| Q2 2020 | $31,000 | -39.2% | 17,147 | -30.1% | 0.00% | +33.3% |
| Q2 2019 | $51,000 | -10.5% | 24,548 | +117.5% | 0.00% | 0.0% |
| Q4 2017 | $57,000 | – | 11,287 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Whitefort Capital Management, LP | 11,895,477 | $24,147,818 | 12.66% |
| Two Seas Capital LP | 8,280,818 | $16,810,061 | 3.38% |
| FourWorld Capital Management LLC | 1,341,907 | $2,724,071 | 0.51% |
| Tejara Capital Ltd | 180,077 | $365,556 | 0.21% |
| Woodline Partners LP | 4,719,903 | $9,581,403 | 0.11% |
| Hudson Bay Capital Management LP | 8,299,808 | $16,848,610 | 0.07% |
| Kepos Capital LP | 155,691 | $316 | 0.06% |
| Virtus ETF Advisers LLC | 40,040 | $81,281 | 0.05% |
| Centiva Capital, LP | 1,071,705 | $2,175,561 | 0.05% |
| Kades & Cheifetz LLC | 20,000 | $40,600 | 0.03% |